跳至主要内容
临床试验/ACTRN12615000726550
ACTRN12615000726550终止1 期

Feasibility of monitoring the motion of lung tumours with kilovoltage intrafraction monitoring

epean and Blue Mountains Local Health District0 个研究点目标入组 24 人开始时间: 2015年7月15日最近更新:
适应症

试验速览

阶段
1 期
状态
终止
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Patient equal to or greater than 18 years of age
  • 2. Patient with NSCLC or SCLC who are assessed as suitable for radical radiotherapy or chemo radiotherapy
  • 3. Tumour greater than or equal to 5mm diameter
  • 4. Tumour suitably positioned for fiducial insertion with linear EBUS
  • 5. Patient does not have medical co-morbidities which preclude EBUS and fiducial insertion.
  • 6. Centrally positioned primary and/or lymph nodes as identified by staging investigations such as CT scan of chest and/or PET scan.
  • 7. Patients with curative intent

排除标准

  • 1. Pregnant women and children under the age of 18;
  • 2. Patients unable to give informed consent;
  • 3. Patients with cardiac pacemakers and patients on anticoagulants.

研究者

发起方
epean and Blue Mountains Local Health District

相似试验